Alto Neuroscience ANRO Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $20.29M+69.2% | $12M+14.0% | $10.53M-19.8% | $13.12M+31.6% | $9.97M-7.6% | ||
| $6.84M+35.3% | $5.06M+14.3% | $4.43M-20.4% | $5.56M-2.5% | $5.7M-8.0% | ||
| $27.14M+59.1% | $17.06M+14.1% | $14.95M-20.0% | $18.68M+19.2% | $15.68M-7.8% | ||
| -$27.14M-59.1% | -$17.06M-14.1% | -$14.95M+20.0% | -$18.68M-19.2% | -$15.68M+7.8% | ||
| $545K-5.2% | $575K-11.5% | $650K+0.6% | $646K+8.0% | $598K+79.6% | ||
| $901K+3.2% | $873K+13.4% | $770K-21.1% | $976K+92.5% | $507K-71.8% | ||
| -$26.24M-62.1% | -$16.18M-14.1% | -$14.18M+19.9% | -$17.71M-16.7% | -$15.17M+0.2% | ||
| -$0.80-77.8% | -$0.45+13.5% | -$0.52+20.0% | -$0.65-16.1% | -$0.560.0% | ||
| -$26.95M-59.5% | -$16.9M-14.6% | -$14.75M+20.6% | -$18.58M-19.8% | -$15.51M+7.9% | ||
| -$27.14M-59.1% | -$17.06M-14.1% | -$14.95M+20.0% | -$18.68M-19.2% | -$15.68M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Alto Neuroscience profitable?
- Alto Neuroscience is not currently profitable: it reported a net loss of $74.3M over the trailing twelve months.
- What is Alto Neuroscience's earnings per share?
- Alto Neuroscience's diluted EPS over the trailing twelve months is $-2.42.
- Where does Alto Neuroscience's income statement data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.